JP Morgan Chase’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,200
| Closed | -$223K | – | 7494 |
|
|
2025
Q2 | $223K | Buy |
+4,200
| New | +$213K | ﹤0.01% | 5182 |
|
|
2024
Q4 | – | Sell |
-5,900
| Closed | -$402K | – | 7476 |
|
|
2024
Q3 | $402K | Sell |
5,900
-29,200
| -83% | -$1.65M | ﹤0.01% | 5049 |
|
|
2024
Q2 | $1.48M | Sell |
35,100
-38,300
| -52% | -$2.11M | ﹤0.01% | 4002 |
|
|
2024
Q1 | $5.07M | Buy |
+73,400
| New | +$4.64M | ﹤0.01% | 3096 |
|
|
2023
Q2 | – | Sell |
-1,200
| Closed | -$81K | – | 7035 |
|
|
2023
Q1 | $81K | Sell |
1,200
-25,800
| -96% | -$1.66M | ﹤0.01% | 5519 |
|
|
2022
Q4 | $1.34M | Buy |
27,000
+20,300
| +303% | +$829K | ﹤0.01% | 3861 |
|
|
2022
Q3 | $218K | Buy |
6,700
+1,200
| +22% | +$49.5K | ﹤0.01% | 4906 |
|
|
2022
Q2 | $217K | Hold |
5,500
| – | – | ﹤0.01% | 5037 |
|
|
2022
Q1 | $385K | Buy |
+5,500
| New | +$402K | ﹤0.01% | 4859 |
|
|
2020
Q3 | – | Sell |
-32,200
| Closed | -$2.8M | – | 5546 |
|
|
2020
Q2 | $2.8M | Hold |
32,200
| – | – | ﹤0.01% | 2881 |
|
|
2020
Q1 | $1.87M | Sell |
32,200
-1,011,700
| -97% | -$82.1M | ﹤0.01% | 3014 |
|
|
2019
Q4 | $96.5M | Buy |
+1,043,900
| New | +$91.8M | 0.02% | 680 |
|
|
2019
Q3 | – | Sell |
-27,000
| Closed | -$3.11M | – | 5792 |
|
|
2019
Q2 | $3.11M | Buy |
27,000
+7,000
| +35% | +$705K | ﹤0.01% | 3051 |
|
|
2019
Q1 | $1.73M | Buy |
+20,000
| New | +$1.7M | ﹤0.01% | 3429 |
|
|
2018
Q4 | – | Sell |
-57,000
| Closed | -$4.5M | – | 5747 |
|
|
2018
Q3 | $4.5M | Buy |
+57,000
| New | +$3.72M | ﹤0.01% | 2825 |
|
|
2018
Q2 | – | Sell |
-27,000
| Closed | -$1.09M | – | 5571 |
|
|
2018
Q1 | $1.09M | Sell |
27,000
-13,000
| -33% | -$634K | ﹤0.01% | 3630 |
|
|
2017
Q4 | $2.1M | Buy |
+40,000
| New | +$2.14M | ﹤0.01% | 3293 |
|
|
2015
Q2 | – | Sell |
-1,000,000
| Closed | -$22M | – | 4057 |
|
|
2015
Q1 | $22M | Hold |
1,000,000
| – | – | 0.01% | 1372 |
|
|
2014
Q4 | $27.4M | Hold |
1,000,000
| – | – | 0.01% | 1270 |
|
|
2014
Q3 | $19.4M | Buy |
+1,000,000
| New | +$18.3M | ﹤0.01% | 1466 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
JP Morgan Chase's EXAS Position: Q1 2026 in Review
JP Morgan Chase sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 674,621 shares — an estimated $68.5M sold.
JP Morgan Chase first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.41B in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- JP Morgan Chase reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- JP Morgan Chase sold 674,621 Exact Sciences shares in Q1 2026, an estimated $68.5M.
- JP Morgan Chase first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
- JP Morgan Chase's Exact Sciences position peaked at $1.41B in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.